Evidence map›Paper›PMID 24711884›Full record

ArticleThe Pan African medical journal2014

Factors associated with interruption of treatment among Pulmonary Tuberculosis patients in Plateau State, Nigeria. 2011.

Luka Mangveep Ibrahim, Idris Suleiman Hadejia, Patrick Nguku, Raymond Dankoli, Ndadilnasiya Endie Waziri, Moses Obiemen Akhimien, Samuel Ogiri, Akin Oyemakinde, Ibrahim Dalhatu, Okey Nwanyanwu and 1 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Understanding the gaps in DR-TB care cascade in Nigeria: A sequential mixed-method study.Journal of clinical tuberculosis and other mycobacterial diseases · 2020
    Article
  17. Article
  18. Article
  19. Governance of tuberculosis control programme in Nigeria.Infectious diseases of poverty · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luka Mangveep IbrahimNigeria Field Epidemiology and Laboratory Training Program, Nigeria.
Idris Suleiman HadejiaDepartment of Community Medicine, Ahmadu Bello University, Zaria, Nigeria.
Patrick NgukuNigeria Field Epidemiology and Laboratory Training Program, Nigeria.
Raymond DankoliNigeria Field Epidemiology and Laboratory Training Program, Nigeria.
Ndadilnasiya Endie WaziriNigeria Field Epidemiology and Laboratory Training Program, Nigeria.
Moses Obiemen AkhimienNigeria Field Epidemiology and Laboratory Training Program, Nigeria.
Samuel OgiriWorld Health Organization, Nigeria.
Akin OyemakindeNigeria Field Epidemiology and Laboratory Training Program, Nigeria.
Ibrahim DalhatuCenters for Disease Control and Prevention, Nigeria Country Office, Abuja Nigeria.
Okey NwanyanwuCenters for Disease Control and Prevention, Nigeria Country Office, Abuja Nigeria.
Peter NsubugaGlobal Public Health Solution, Decatur GA USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionNigeria has one of the highest tuberculosis (TB) burdens in the world with estimated incidence of 133 per 100,000 populations. Multi-drug resistant TB (MDR-TB) is an emerging threat of the TB control in Nigeria caused mainly by incomplete treatment. This study explored factors that affect adherence to treatment among patients undergoing direct observation of TB treatment in Plateau state, Nigeria.

methodsBetween June and July 2011, we reviewed medical records and interviewed randomly selected pulmonary TB patients in their eighth month of treatment. Information on patients? clinical, socio-demographic and behavioral characteristics was collected using checklist and structured questionnaire for knowledge of treatment duration and reasons for interruption of treatment. We conducted focus group discussions with patients about barriers to treatment adherence. Data were analyzed with Epi Info software.

resultsOf 378 records reviewed, 229 (61%) patients were male; mean age 37.6±13.5 years and 71 (19%) interrupted their treatment. Interruption of treatment was associated with living >5 km from TB treatment site (AOR: 11.3; CI 95%: 5.7-22.2), lack of knowledge of duration of treatment (AOR: 6.1; CI 95%: 2.8-13.2) and cigarette smoking (AOR: 3.4; CI 95%: 1.5- 8.0). Major reasons for the interruption were lack of transport fare (40%) and feeling well (25%). Focused group discussions revealed unfriendly attitudes of health care workers as barriers to adherence to treatment.

conclusionThis study revealed knowledge of the patients on the duration of treatment, distance and health workers attitude as the major determinants of adherent to TB treatment. Training for health care workers on patient education was conducted during routine supportive supervision.

Indexed as

Directly Observed TherapyMedication AdherenceAdolescentAdultAntitubercular AgentsAttitude of Health PersonnelFemaleFocus GroupsHealth Knowledge, Attitudes, PracticeHealth PersonnelHumansIncidenceMaleMiddle AgedNigeriaPatient Education as TopicAntitubercular AgentsInterruptionNigeriatreatmentTuberculosis

Identifiers

PMID24711884
PMCPMC3972906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.